4-methoxybenzenesulfinate
Star0
Identification
- Generic Name
- 4-methoxybenzenesulfinate
- DrugBank Accession Number
- DB03033
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 171.19
Monoisotopic: 171.012138839 - Chemical Formula
- C7H7O3S
- Synonyms
- 1-methyloxy-4-sulfone-benzene
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UCollagenase 3 Not Available Humans UStromelysin-1 Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- YVZWQPOTHRMEQW-UHFFFAOYSA-M
- InChI
- InChI=1S/C7H8O3S/c1-10-6-2-4-7(5-3-6)11(8)9/h2-5H,1H3,(H,8,9)/p-1
- IUPAC Name
- 4-methoxybenzene-1-sulfinate
- SMILES
- COC1=CC=C(C=C1)S([O-])=O
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 17.9 mg/mL ALOGPS logP 0.63 ALOGPS logP 0.78 Chemaxon logS -1 ALOGPS pKa (Strongest Acidic) 1.65 Chemaxon pKa (Strongest Basic) -4.8 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 49.36 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 42.55 m3·mol-1 Chemaxon Polarizability 16.19 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9957 Blood Brain Barrier + 0.9102 Caco-2 permeable - 0.5136 P-glycoprotein substrate Non-substrate 0.8248 P-glycoprotein inhibitor I Non-inhibitor 0.7818 P-glycoprotein inhibitor II Non-inhibitor 0.9781 Renal organic cation transporter Non-inhibitor 0.8482 CYP450 2C9 substrate Non-substrate 0.6629 CYP450 2D6 substrate Non-substrate 0.7837 CYP450 3A4 substrate Non-substrate 0.6253 CYP450 1A2 substrate Inhibitor 0.7537 CYP450 2C9 inhibitor Inhibitor 0.6793 CYP450 2D6 inhibitor Non-inhibitor 0.9212 CYP450 2C19 inhibitor Inhibitor 0.7185 CYP450 3A4 inhibitor Non-inhibitor 0.9234 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.6532 Ames test Non AMES toxic 0.7049 Carcinogenicity Non-carcinogens 0.5232 Biodegradation Ready biodegradable 0.7582 Rat acute toxicity 2.3603 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8789 hERG inhibition (predictor II) Non-inhibitor 0.9066
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsCollagenase 3
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III co...
- Gene Name
- MMP13
- Uniprot ID
- P45452
- Uniprot Name
- Collagenase 3
- Molecular Weight
- 53819.32 Da
References
2. DetailsStromelysin-1
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase.
- Gene Name
- MMP3
- Uniprot ID
- P08254
- Uniprot Name
- Stromelysin-1
- Molecular Weight
- 53976.84 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52